[{"id":"cbdac200-fe8e-4b55-ad12-6ac910522add","acronym":"PRECISIONV","url":"https://clinicaltrials.gov/study/NCT00261378","created_at":"2021-01-18T00:53:16.721Z","updated_at":"2024-07-02T16:36:27.626Z","phase":"Phase 2","brief_title":"Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation","source_id_and_acronym":"NCT00261378 - PRECISIONV","lead_sponsor":"Boston Scientific Corporation","biomarkers":" AFP","pipe":"","alterations":" ","tags":["AFP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e DC Bead (E7040)"],"overall_status":"Completed","enrollment":" Enrollment 212","initiation":"Initiation: 11/01/2005","start_date":" 11/01/2005","primary_txt":" Primary completion: 01/01/2008","primary_completion_date":" 01/01/2008","study_txt":" Completion: 01/01/2008","study_completion_date":" 01/01/2008","last_update_posted":"2021-07-21"},{"id":"cc1b6bdf-3c1d-4477-901e-9bfb667da8fb","acronym":"","url":"https://clinicaltrials.gov/study/NCT02015754","created_at":"2021-01-18T09:13:17.696Z","updated_at":"2024-07-02T16:37:12.878Z","phase":"Phase 2","brief_title":"Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer","source_id_and_acronym":"NCT02015754","lead_sponsor":"Yale University","biomarkers":" CEACAM5","pipe":"","alterations":" ","tags":["CEACAM5"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e irinotecan • DC Bead (E7040)"],"overall_status":"Completed","enrollment":" Enrollment 14","initiation":"Initiation: 02/01/2014","start_date":" 02/01/2014","primary_txt":" Primary completion: 06/02/2015","primary_completion_date":" 06/02/2015","study_txt":" Completion: 12/13/2016","study_completion_date":" 12/13/2016","last_update_posted":"2018-03-22"}]